Send to

Choose Destination
J Pain Res. 2017 Feb 14;10:383-387. doi: 10.2147/JPR.S129553. eCollection 2017.

Secular trends in opioid prescribing in the USA.

Author information

Bioconsult, LLC, Wethersfield.
Purdue Pharma L.P., Stamford, CT.
Purdue Pharma L.P., Stamford, CT; Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA.


Opioid abuse and misuse in the USA is a public health crisis. The use of prescription opioid analgesics increased substantially from 2002 through 2010, then plateaued and began to decrease in 2011. This study examined prescriptions of branded and generic immediate- and extended-release opioid analgesics from 1992 to 2016. This was juxtaposed against state and federal policies designed to decrease overutilization and abuse, as well as the launch of new opioid products, including opioids with abuse-deterrent properties (OADPs). The data indicate that these health policies, including the utilization and reimbursement of OADPs, have coincided with decreased opioid utilization. The hypothesis that OADPs will paradoxically increase opioid prescribing is not supported.


OADP; legislation; opioids; prescription; utilization trends

Conflict of interest statement

Disclosure EJP is a consultant. DR, JGE, JDH, and TJM are employees of Purdue Pharma L.P. The authors report no other conflicts of interest in this work.

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center